Medication exposure in pregrancy (MEPREP) opioids use and NTD's feasibility assessment

Ended Awarded Last action

Contract number
HHSF22301010T
Awardee
Awarding agency
Obligated
$255,223

Award facts

Contract value 100% obligated
$255,222.67 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541712 Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
PSC
B537 Special Studies/Analysis- Medical/Health
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Wellesley Hills, Wellesley, MA 02481, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 · Igfcligf medication exposure in pregrancy (MEPREP) opioids use and NTD's feasibility assessment -$24,400
Change Order 2 $0
Other Administrative Action 1 $0
Original award $279,623

Quick answers

Who was awarded contract HHSF22301010T?

HHSF22301010T was awarded to Harvard Pilgrim Health Care, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 12, 2014.

How much is contract HHSF22301010T worth?

The government has obligated $255,223 on HHSF22301010T.

Is contract HHSF22301010T an order under another contract?

Yes. HHSF22301010T is a delivery order under HHSF223201000009I, an indefinite delivery contract.

Was contract HHSF22301010T competed?

The extent of competition for HHSF22301010T was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award